Curaleaf Holdings Inc. (CURA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Curaleaf Holdings Inc. (CURA) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$48.44 Million ≈ $35.04 Million USD) by net assets (CA$886.23 Million ≈ $641.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Curaleaf Holdings Inc. - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Curaleaf Holdings Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CURA liabilities breakdown for a breakdown of total debt and financial obligations.

Curaleaf Holdings Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Curaleaf Holdings Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TMC the metals company Inc NASDAQ:TMC	0.283x
Sino-Platinum Metals Co Ltd SHG:600459	-0.111x
KPIT Technologies Limited NSE:KPITTECH	0.112x
Calumet Specialty Products Partners NASDAQ:CLMT	-0.223x
Kaiser Aluminum Corporation NASDAQ:KALU	-0.025x
Alupar Investimento SA SA:ALUP11	0.039x
Carl Zeiss Meditec AG F:AFX	0.068x
BW LPG Limited NYSE:BWLP	0.092x

Annual Cash Flow Conversion Efficiency for Curaleaf Holdings Inc. (2014–2024)

The table below shows the annual cash flow conversion efficiency of Curaleaf Holdings Inc. from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see CURA market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$993.39 Million ≈ $718.61 Million	CA$162.57 Million ≈ $117.60 Million	0.164x	+154.69%
2023-12-31	CA$1.17 Billion ≈ $847.29 Million	CA$75.26 Million ≈ $54.44 Million	0.064x	+93.98%
2022-12-31	CA$1.40 Billion ≈ $1.01 Billion	CA$46.40 Million ≈ $33.57 Million	0.033x	+262.39%
2021-12-31	CA$1.67 Billion ≈ $1.20 Billion	CA$-33.96 Million ≈ $-24.57 Million	-0.020x	-327.21%
2020-12-31	CA$1.38 Billion ≈ $995.53 Million	CA$12.36 Million ≈ $8.94 Million	0.009x	+109.45%
2019-12-31	CA$403.45 Million ≈ $291.85 Million	CA$-38.32 Million ≈ $-27.72 Million	-0.095x	-25.01%
2018-12-31	CA$435.64 Million ≈ $315.14 Million	CA$-33.10 Million ≈ $-23.94 Million	-0.076x	-3.18%
2017-12-31	CA$104.77 Million ≈ $75.79 Million	CA$-7.71 Million ≈ $-5.58 Million	-0.074x	+97.51%
2016-12-31	CA$36.18K ≈ $26.17K	CA$-106.89K ≈ $-77.32K	-2.954x	-174.61%
2015-12-31	CA$143.03K ≈ $103.46K	CA$-153.88K ≈ $-111.31K	-1.076x	-215.61%
2014-12-31	CA$72.86K ≈ $52.71K	CA$-24.84K ≈ $-17.97K	-0.341x	--

About Curaleaf Holdings Inc.

TO:CURA Canada Drug Manufacturers - Specialty & Generic

Market Cap

$2.23 Billion

CA$3.09 Billion CAD

Market Cap Rank

#5867 Global

#189 in Canada

Share Price

CA$4.59

Change (1 day)

-3.77%

52-Week Range

CA$1.07 - CA$6.49

All Time High

CA$18.62